Thomas Equels bought $5K of AIM ImmunoTech stock

By AlphaYouPublished Oct 23, 2026Form 4

Stocks in this disclosure

Reported activity

Equels Thomas K

Reporting filer

Thomas Equels reported buying 31,250 shares of AIM ImmunoTech Inc. for about $5K ($0.16 a share on average). Form 4 filed Oct 23, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Equels Thomas K	2026-10-22	P	Purchase	31250	0.163	158,072	1 day	Filed terms security Title: Common Stock transaction Date: 2026-10-22 deemed Execution Date: transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 31250 transaction Price Per Share: 0.163 transaction Acquired Disposed Code: A shares Owned Following Transaction: 158072 direct Or Indirect Ownership: D

Owner: Equels Thomas K
Date: 2026-10-22
Code: P
Action: Purchase
Quantity: 31250
Price: 0.163
Following holdings: 158,072
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-22
deemed Execution Date:
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 31250
transaction Price Per Share: 0.163
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 158072
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Equels Thomas K: CEO & President, Director.

Prepared automatically from public filing data. Report a correction.